Formulation of nicotine mucoadhesive tablet for smoking cessation and evaluation of its pharmaceuticals properties

Authors
Rahim Bahri-Najafi 1
Zahra Rezaei 2
Mohammad Peykanpour 1
Leyla Shabab 2
Reza Solooki 3
Pooya Akbari 3
1 Department of Pharmaceutics, Faculty of Pharmacy, Isfahan University of Medical Sciences, Shiraz, Iran
2 Department of Pharmaceutics, Shiraz University of Medical Sciences, Shiraz, Iran
3 Faculty of Internal medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: Nicotine replacement therapy (NRT) with gradual decreasing of nicotine is one of the smoking cessation methods. Muccoadhesive formulations are among the novel drug delivery systems that are available in the form of tablets and films, and can be used for NRT. Muccoadhesive nicotine tablets when placed in the upper gum will attach to the buccal mucosa and release nicotine content in a controlled manner. This will meet the immediate and long-term need of the individual to the nicotine, such that the person can decrease his/her dependency on smoking. [1]
Materials and Methods: In this study, the tablets were prepared using different conventional bioadhesive polymers such as Hydroxypropyl Methycellulose (HPMC) 50cps, sodium carboxy methyl cellulose (NaCMC), and carbapol 934 (CP934) in singular or mixture form. Magnesium hydroxide were used as the pH increasing agent; magnesium stearate as the lubricant; and lactose as the excipiente. Nicotine hydrogen bitartrate, more stable than the liquid, was used in different formulations. Pharmaceutics characteristics such as adhesion degree and drug release rate were evaluated.
Results: Increasing of HPMC 50cps in the formulations decrease speed release of nicotine. The carbapol in formulations beget slow releasing of nicotine. With increasing the percent of lactose, the rate of release in formulations was increased. Formulations, which have HPMC 50cps has best adhesiveness and the formulations contains carbapol had not suitable adhesiveness. Formulations contains NaCMC were very fast release and had not suitable adhesiveness.
Conclusion: The formulation contains mixture of HPMC50cps and CP934 was the best because of suitable adhesiveness and minimum swing in release.

Keywords

1. Lewis S, Subramanian G, Pandey S, and Udupa N. Design, evaluation and pharmacokinetic study of mucoadhesive buccal tablets of nicotine for smoking cessation. Indian J Pharm Sci 2006;68:829-31.  Back to cited text no. 1
  Medknow Journal  
2. Shiffman S, Hughes JR, Pillitteri JL, Burton SL. Persistent use of nicotine replacement therapy: An analysis of actual purchase patterns in a population based sample. Tob Control 2003;12:310-6.  Back to cited text no. 2
[PUBMED]    
3. Ikinci G, Senel S, Tokgözoðlu L, Wilson CG, Sumnu M. Development and in vitro /in vivo evaluations of bioadhesive buccal tablets for nicotine replacement therapy. Pharmazie 2006;61:203-7.  Back to cited text no. 3
    
4. PDR physician desk reference, 60 ed. nicotine monograph. 2006. p. 1632-4.  Back to cited text no. 4
    
5. Rubinstein ML, Benowitz NL, Auerback GM, Moscicki AB. A randomized trial of nicotine nasal spray in adolescent smokers. Pediatrics 2008;122:e595-600.  Back to cited text no. 5
[PUBMED]    
6. Nafee NA, Ismail FA, Boraie NA, Mortada LM. Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulation. Drug Dev Ind Pharm 2004;30:985-93.  Back to cited text no. 6
    
7. Metia PK, Bandyopadhyay AK. In vitro evaluation of novel mucoadhesive buccal tablet of oxytocin prepared with Diospyros peregrina fruit mucilages. Yakugaku Zasshi 2008;128:603-9.  Back to cited text no. 7
[PUBMED]    
8. Bouckaert S, Schautteet H, Lefebvre RA, Remon JP, van Clooster R. Comparison of salivary miconazole concentrations after administration of a bioadhesive slow-release buccal tablet and an oral gel. Eur J Clin Pharmacol 1992;43:137-40.  Back to cited text no. 8
[PUBMED]    
9. Patel Geeta M, Anita P. A novel effervescent bioadhesive vaginal tablet of ketoconazole: Formulation and in vitro evaluation. Int J PharmTech Res 2010;2:656-67.  Back to cited text no. 9
    
10. Wern ME. Medications to aid smoking cessation. Adv Stud Med 2003;3:507-16.  Back to cited text no. 10
    
11. Kumar SV, Gavaskar B, Sharan G, Rao YM. Overview on fast dissolving films. Int J Pharm Pharm Sci 2010;2:29-33.  Back to cited text no. 11
    
12. Salamat-Miller N, Chittchang M, Johnston TP. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev 2005;57:1666-91.  Back to cited text no. 12
[PUBMED]    
13. Peppas NA, Huang Y. Nanoscale technology of mucoadhesive interactions. Adv Drug Deliv Rev 2004;56:1675-87.  Back to cited text no. 13
[PUBMED]    
14. Tiwari SB, Rajabi-Siahboomi AR. Modulation of drug release from hydrophilic matrices. Pharm Techn Europe 2008;1:1-8.  Back to cited text no. 14
    
15. Shaila L, Subramanian G, Pandey S, Udupa N. Design, evaluation and pharmacokinetic study of mucoadhesive buccal tablets of nicotine for smoking cessation. Indian J Pharm Sci 2006;68:829-31.  Back to cited text no. 15
    
Advanced Biomedical Research
Volume 2013, November
November 2013
Pages 1-9